(2019). Corrigendum to: Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial. Eur Heart J.
Citação norma Chicago"Corrigendum To: Uninterrupted Edoxaban Vs. Vitamin K Antagonists for Ablation of Atrial Fibrillation: The ELIMINATE-AF Trial." Eur Heart J 2019.
MLA citiranje"Corrigendum To: Uninterrupted Edoxaban Vs. Vitamin K Antagonists for Ablation of Atrial Fibrillation: The ELIMINATE-AF Trial." Eur Heart J 2019.
Opozorilo: Ti citati niso vedno 100% točni.